12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study

PloS One
SeyedHossein RabaniFarzad Hadaegh

Abstract

To examine the trend of cardiovascular diseases (CVD) risk factors among a Middle Eastern population with prevalent CVD during a median follow up of 12 years. Patients with prevalent CVD (n = 282, men = 167), with a mean age of 60.76 years were evaluated in four study phases of the TLGS (Tehran lipid glucose study), 2002-2005, 2005-2008, 2008-2011, and 2011-2014. Trends of CVD risk factors were estimated using generalized estimation equation (GEE) models, by adjusting for gender, age and propensity scores. The adjusted prevalence of general and central adiposity, diabetes and physical inactivity at baseline was 25.18, 60.14, 25.03 and 43.74%, respectively and had increasing trends during the study period, reaching 41.32, 66.74, 43.20 and 50.32%, respectively, at the last visit. Although systolic, but not diastolic blood pressure, decreased from 134.88 to 129.86 mmHg, the prevalence of hypertension did not decrease (64.21% vs 68%, p value = 0.326). The prevalence of low high density lipoprotein cholesterol (HDL-C), hypertriglyceridemia and high non-HDL-C at baseline was 74.54, 59.89 and 96.53%, respectively, and showed improved trends reaching 44.87, 47.12 and 96.06% respectively; however, the favorable trend was not observed fo...Continue Reading

References

Nov 7, 2002·American Journal of Epidemiology·Donna K ArnettRussell V Luepker
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Umesh N KhotEric J Topol
Jul 21, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Daniel E WeinerMark J Sarnak
Oct 27, 2004·Expert Review of Cardiovascular Therapy·Angie Veverka, Jamie L Jolly
Mar 3, 2007·Clinical Chemistry·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Sep 4, 2007·Lancet·Lars H Lindholm, Shanthi Mendis
Jan 27, 2009·Trials·Fereidoun AziziUNKNOWN Tehran Lipid and Glucose Study Group
Apr 29, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Bahareh MotlaghSalim Yusuf
Sep 16, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·F HadaeghF Azizi
Sep 22, 2009·American Journal of Preventive Medicine·Vicki S ConnSally L Lusk
May 22, 2010·Lipids in Health and Disease·Yunqin ChenHaozhu Chen
Mar 3, 2011·JAMA : the Journal of the American Medical Association·Angela M ThompsonLydia A Bazzano
Jun 20, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lesley A Inker, Andrew S Levey
Aug 31, 2013·Stroke; a Journal of Cerebral Circulation·Bruce OvbiageleUNKNOWN PRoFESS Investigators
Mar 26, 2014·Nature Reviews. Cardiology·Nathan D Wong
Apr 10, 2014·BMC Public Health·Analice GigliottiRonaldo Laranjeira
Nov 5, 2014·British Journal of Clinical Pharmacology·Mary A De VeraDiane Lacaille
Feb 18, 2015·European Journal of Preventive Cardiology·Kornelia KotsevaUNKNOWN on behalf of the EUROASPIRE Investigators
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Oct 9, 2019·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Nazanin FekriFarzad Hadaegh
Oct 15, 2021·European Radiology·Josua A DeckerChristian Scheurig-Muenkler

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

STATA

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.